AndreaBozzo/ceres-open-data-index huggingface dataset:
Reliability and cultural applicability of the Greek version of the International Personality Disorders Examination.

Background
          The International Personality Disorders Examination (IPDE) constitutes the proposal of the WHO for the reliable diagnosis of personality disorders (PD). The IPDE assesses pathological personality and is compatible both with DSM-IV and ICD-10 diagnosis. However it is important to test the reliability and cultural applicability of different IPDE translations.
        
        
          Methods
          Thirty-one patients (12 male and 19 female) aged 35.25 ± 11.08 years, took part in the study. Three examiners applied the interview (23 interviews of two and 8 interviews of 3 examiners, that is 47 pairs of interviews and 70 single interviews). The phi coefficient was used to test categorical diagnosis agreement and the Pearson Product Moment correlation coefficient to test agreement concerning the number of criteria met.
        
        
          Results
          Translation and back-translation did not reveal specific problems. Results suggested that reliability of the Greek translation is good. However, socio-cultural factors (family coherence, work environment etc) could affect the application of some of the IPDE items in Greece. The diagnosis of any PD was highly reliable with phi >0.92. However, diagnosis of non-specfic PD was not reliable at all (phi close to 0) suggesting that this is a true residual category. Dianosis of specific PDs were highly reliable with the exception of schizoid PD. Diagnosis of antisocial and Borderline PDs were perfectly reliable with phi equal to 1.00.
        
        
          Conclusions
          The Greek translation of the IPDE is a reliable instrument for the assessment of personality disorder but cultural variation may limit its applicability in international comparisons.
Compound 526872: 2-(2-(2-Isobutoxy-ethoxy)-ethoxy)-ethyl acetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-(2-methylpropoxy)ethoxy]ethoxy]ethyl acetate. Molecular Formula: C12H24O5. Molecular Weight: 248.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525495: 5-Methyl-4,6-dithia-1,8-nonadiene

Chemical compound data from PubChem database. IUPAC Name: 3-(1-prop-2-enylsulfanylethylsulfanyl)prop-1-ene. Molecular Formula: C8H14S2. Molecular Weight: 174.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Trend Tables (Standard Errors and P Values) - 7.1 to 7.45

These detailed tables show standard errors for trends in totals and prevalence estimates of illicit drug use, risk and protective factors, substance initiation, substance dependence/abuse, and need/receipt of substance use treatment from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy, Ketamine, DMT/AMT/Foxy, Salvia divinorum), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants (Adderall), sedatives (GHB, Ambien), non-prescription cold medicine, alcohol, and tobacco products (including cigarettes, smokeless tobacco, cigars, pipes). Standard errors are provided for totals and estimates of lifetime, past year, and past month use by age group, gender, race/ethnicity, education level, employment status, and geographic area.
Compound 526536: [7-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl] 2-methylbut-2-enoate

Chemical compound data from PubChem database. IUPAC Name: [7-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl] 2-methylbut-2-enoate. Molecular Formula: C13H21NO3. Molecular Weight: 239.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530743: 3-Fluorobenzoic acid, 2-methyloct-5-yn-4-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2-methyloct-5-yn-4-yl 3-fluorobenzoate. Molecular Formula: C16H19FO2. Molecular Weight: 262.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526446: 6,7,8,9-Tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one

Chemical compound data from PubChem database. IUPAC Name: 6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one. Molecular Formula: C8H10N2O. Molecular Weight: 150.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Continuing medical education in Turkey: Recent developments

Background
          The Turkish Association of Medicine founded a Continuing Medical Education Accreditation Committee in 1993 to evaluate and accredit scientific meetings and publications. The aims of this project were to raise the standards of meetings and to introduce compulsory revalidation and re-certification for physicians in Turkey.
        
        
          Discussion
          Since the year 1994, 2348 applications to the Continuing Medical Education board have been made (mostly for scientific meetings), and 95% of these applications have been accepted. Physicians received 139.014 credits during this time. This number is increasing every year. Meeting organisers' demand for such a kind of evaluation is increasing, because participants increasingly request it.
        
        
          Summary
          Efforts for revalidation and re-certification of physicians have not been completely successful yet. In the near future the Co-ordination Council of Medical Speciality Societies is going to oblige member associations to establish speciality boards. This will be the first step to the conventional use of Continuing Medical Education credits in occupational evaluation. Time-limited re-certification of physicians is the principal goal of Turkish Medical Association. Efforts to implement this change in legislation are being made.
Uniform Facility Data Set  US (UFDS-1998)

<p>The Uniform Facility Data Set (UFDS) was designed to measure the scope and use of drug abuse treatment services in the United States. The survey collects information from each privately- and publicly-funded facility in the country that provides substance abuse treatment as well as from state-identified facilities that provide other substance abuse services. Data are collected on a number of topics including facility operation, services provided (assessment, therapy, testing, health, continuing care, special programs, transitional services, community outreach, ancillary), type of treatment, numbers of clients, and various client characteristics. The main objective of the UFDS is to produce data that can be used to assess the nature and extent of substance abuse treatment services, to assist in the forecast of treatment resource requirements, to analyze treatment service trends, to conduct national, regional, and state-level comparative analyses of treatment services and utilization, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its on-line equivalent, the Substance Abuse Treatment Facility Locator <a href="http://findtreatment.samhsa.gov/.This">http://findtreatment.samhsa.gov/.This</a> study has 1 Data Set.</p>
South Dakota (SD)

This report presents South Dakota\'s estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for South Dakota for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 525677: 3-Chloro-N-(4-chlorobenzylidene)aniline

Chemical compound data from PubChem database. IUPAC Name: N-(3-chlorophenyl)-1-(4-chlorophenyl)methanimine. Molecular Formula: C13H9Cl2N. Molecular Weight: 250.12. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Experimental arthritis induced by a clinical

Background
          Mycoplasma fermentans has been associated with rheumatoid arthritis. Recently, it was detected in the joints and blood of patients with rheumatoid arthritis, but it is not clear yet how the bacteria enter the body and reach the joints. The purpose of this study was to determine the ability of M. fermentans to induce experimental arthritis in rabbits following inoculation of the bacteria in the trachea and knee joints.
        
        
          Methods
          P-140 and PG-18 strains were each injected in the knee joints of 14 rabbits in order to evaluate and compare their arthritogenicity. P-140 was also injected in the trachea of 14 rabbits in order to test the ability of the bacteria to reach the joints and induce arthritis.
        
        
          Results
          M. fermentans produced an acute arthritis in rabbits. Joint swelling appeared first in rabbits injected with P-140, which caused a more severe arthritis than PG-18. Both strains were able to migrate to the uninoculated knee joints and they were detected viable in the joints all along the duration of the experiment. Changes in the synovial tissue were more severe by the end of the experiment and characterized by the infiltration of neutrophils and substitution of adipose tissue by connective tissue. Rabbits intracheally injected with P-140 showed induced arthritis and the bacteria could be isolated from lungs, blood, heart, kidney, spleen, brain and joints.
        
        
          Conclusion
          M. fermentans induced arthritis regardless of the inoculation route. These findings may help explain why mycoplasmas are commonly isolated from the joints of rheumatic patients.
CMS Program Statistics - Medicare Skilled Nursing Facility

The CMS Program Statistics - Medicare Skilled Nursing Facility tables provide use and payment data for skilled nursing facilities. 

For additional information on enrollment, providers, and Medicare use and payment, visit the CMS Program Statistics page.

 

Below is the list of tables:


	MDCR SNF 1.  Medicare Skilled Nursing Facilities:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Type of Entitlement, Yearly Trend
	MDCR SNF 2.  Medicare Skilled Nursing Facilities:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Demographic Characteristics and Medicare-Medicaid Enrollment Status
	MDCR SNF 3.  Medicare Skilled Nursing Facilities:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Area of Residence
	MDCR SNF 4.  Medicare Skilled Nursing Facilities:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Type of Entitlement and Covered Days of Care
	MDCR SNF 5.  Medicare Skilled Nursing Facilities:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Type of Facility and Bedsize
	MDCR SNF 6.  Medicare Skilled Nursing Facilities:  Distribution of Medicare Covered Skilled Nursing Facility Days, by State of Provider and Major Resource Utilization Groups (RUG)-III (versions 2013-2018 only)
Dietary fiber showed no preventive effect against colon and rectal cancers in Japanese with low fat intake: an analysis from the results of nutrition surveys from 23 Japanese prefectures

Background
          Since Fuchs' report in 1999, the reported protective effect of dietary fiber from colorectal carcinogenesis has led many researchers to question its real benefit. The aim of this study is to evaluate the association between diet, especially dietary fiber and fat and colorectal cancer in Japan.
        
        
          Methods
          A multiple regression analysis (using the stepwise variable selection method) was performed using the standardized mortality ratios (SMRs) of colon and rectal cancer in 23 Japanese prefectures as objective variables and dietary fiber, nutrients and food groups as explanatory variables.
        
        
          Results
          As for colon cancer, the standardized partial correlation coefficients were positively significant for fat (1,13, P = 0.000), seaweeds (0.41, P = 0.026) and beans (0.45, P = 0.017) and were negatively significant for vitamin A (-0.63, P = 0.003), vitamin C (-0.42, P = 0.019) and yellow-green vegetables (-0.37, P = 0.046). For rectal cancer, the standardized partial correlation coefficient in fat (0.60, P = 0.002) was positively significant. Dietary fiber was not found to have a significant relationship with either colon or rectal cancers.
        
        
          Conclusions
          This study failed to show any protective effect of dietary fiber in subjects with a low fat intake (Japanese) in this analysis, which supports Fuchs' findings in subjects with a high fat intake (US Americans).
Patent AT-E399827-T1: [Translated] ABSORBENT AND SLIDING COATING AGENT AND PRODUCTS COATED THEREFROM

Coatings are formed by applying to article a copolymer of a water soluble base polymer having graft polymerized thereto an organic moiety that includes a group that reacts with water to form a silanol group, and then curing the copolymer to form a crosslinked hydrogel coating that is absorbent, lubricious and substantially non-water soluble. Coating compositions, coated articles the subject coatings are also described.
Expression profiles during honeybee caste determination

Background
          Depending on their larval environment, female honeybees develop into either queens or workers. As in other polyphenisms, this developmental switch depends not on genomic differences between queens and workers but on the differential expression of entire suites of genes involved with larval fate. As such, this and other polyphenic systems can provide a novel tool for understanding how genomes and environmental conditions interact to produce different developmental trajectories. Here we use gene-expression profiles during honeybee caste determination to present the first genomic view of polyphenic development.
        
        
          Results
          Larvae raised as queens or workers differed greatly in their gene-expression patterns. Workers remained more faithful than queens to the expression profiles of younger, bipotential, larvae. Queens appeared to both downregulate many of the genes expressed by bipotential larvae and turn on a distinct set of caste-related genes. Queens overexpressed several metabolic enzymes, workers showed increased expression of a member of the cytochrome P450 family, hexameric storage proteins and dihydrodiol dehydrogenase, and young larvae overexpressed two putative heat-shock proteins (70 and 90 kDa), and several proteins related to RNA processing and translation.
        
        
          Conclusions
          Large differences in gene expression between queens and workers indicate that social insect castes have faced strong directional selection pressures. Overexpression of metabolic enzymes by queen-destined larvae appears to reflect the enhanced growth rate of queens during late larval development. Many of the differently expressed genes we identified have been tied to metabolic rates and cellular responses to hormones, a result consistent with known physiological differences between queen and worker larvae.
Compound 525853: N,N-Dimethyl-2-phenyl-N'-(4-bromophenyl)-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(4-bromophenyl)-N,N-dimethyl-2-phenylethanimidamide. Molecular Formula: C16H17BrN2. Molecular Weight: 317.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Program Instruction (PI-13-04)

This Program Instruction (PI) provides instruction to States on the June 30, 2013 submission of the Annual Progress and Services Report (APSR) required under Title IV-B of the Act for the Stephanie Tubbs Jones Child Welfare Services (CWS) and Promoting Safe and Stable Families (PSSF) Programs, the Child Abuse Prevention and Treatment Act (CAPTA) State Grant Program; and the Chafee Foster Care Independence Program (CFCIP) and the Education and Training Vouchers (ETV) Program; and the CFS-101, Part I, Annual Budget Request, Part II, Annual Summary of Child and Family Services, and Part III, Annual Expenditure Report—Title IV-B, subparts 1 and 2, CFCIP, and ETV.

PI-13-04 (PDF)

Fiscal Year 2013 Allotment Title IV-B Subpart 1 Stephanie Tubbs Jones Child Welfare Services
Fiscal Year 2013 Allotment Title IV-B Subpart 2 Promoting Safe and Stable Families
Fiscal Year 2013 Allotment for Title IV-B, Subpart 2 Monthly Caseworker Visit Funds
Fiscal Year 2013 Allotment for CAPTA
Fiscal Year 2013 Allotment for Chafee Foster Care Independence Program
Fiscal Year 2013 Allotment for Education and Training Vouchers

CFS-101 Part I: Annual Budget Request for Title IV-B, subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Program Instructions
CFS-101 Part I: Annual Budget Request for Title IV-B, subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Program Form (XLSX) (Excel 13 KB)
CFS-101, Part II: Annual Summary of Child and Family Services Instructions 
CFS-101, Part II: Annual Summary of Child and Family Services Form (XLSX) (Excel 13 KB)
CFS-101, Part III: Annual Expenditures for Title IV-B, subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Instructions
CFS-101, Part III: Annual Expenditures for Title IV-B, subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Form (XLSX) (Excel 13 KB)

CB Regional Program Managers and Addresses

NCANDS State contact list

Education and Training Voucher Reporting (DOCX) (Word 19 KB)

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 530638: m-Toluic acid, but-3-yn-2-yl ester

Chemical compound data from PubChem database. IUPAC Name: but-3-yn-2-yl 3-methylbenzoate. Molecular Formula: C12H12O2. Molecular Weight: 188.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Impact of rhinitis on airway inflammation: biological and therapeutic implications

There is increasing evidence for a close link between the upper and the lower respiratory tracts and the fact that rhinitis has an important impact on asthma. Several clinical and experimental observations suggest a similar immunopathology between the upper and lower airways in allergic subjects. The common inflammatory process that develops in the respiratory tract explains some of the complex interactions among different clinical diseases such as rhinitis, sinusitis, asthma, bronchial hyperresponsiveness and viral infections. There are also non-inflammatory mechanisms that may contribute to the link between rhinitis and asthma. Moreover, the outcomes of various pharmacological treatments of rhinitis have recently provided further support for the hypothesis of the united airways. We discuss some of the recent observations on the nose-lung interaction and some of the novel therapeutic approaches used to treat rhinitis and asthma that arise from this.
Benefits and Cost Sharing PUF - PY2018

The Benefits and Cost Sharing PUF (BenCS-PUF) is one of the files that make up the Marketplace PUF. The BenCS-PUF contains plan-level data on essential health benefits, coverage limits, and cost sharing for each QHP and SADP. These data either originate from the Plans &amp; Benefits template (i.e., template field), an Excel-based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated).
Patent AT-E40154-T1: [Translated] METHOD OF TREATMENT OF LIQUID METALS USING A CALCIUM-CONTAINING CORRED WIRE.

The method comprises the formation of a liquid metal wherein is introduced a coated wire of which the core contains a material consisting of a calcium alloy, said alloy containing at least 75% by mass of calcium and a total contents of at least 5% by mass of NI + Al. Preferred composition: at least 80% of calcium and up to 20% of Ni and/or Al. The tests carried out by means of the device represented in figure 1 have shown that it is possible to effect the introduction of the coated wire (10) into the flowing steel (2) at a rate from 80 to 120g of Ca per ton of flowing steel and per minute without causing an excessive boil. The invention also relates to the coated wire.
National Immunization Survey Adult COVID Module (NIS-ACM): RespVaxView| Data | Centers for Disease Control and Prevention (cdc.gov)

• National Immunization Survey Adult COVID Module (NIS-ACM): CDC is providing information on the updated 2024-25 COVID-19 vaccine, the 2024-25 seasonal flu vaccine, and the RSV vaccine uptake and confidence. These data represent trends in vaccination status and intent, and other behavioral indicators, by demographics and other characteristics. 

• The data start in September 2024.

• The archived data can be found here: 
- 2023-24 season: https://data.cdc.gov/Vaccinations/National-Immunization-Survey-Adult-COVID-Module-NI/uc4z-hbsd/about_data
- Before October 2023:  
https://data.cdc.gov/Vaccinations/National-Immunization-Survey-Adult-COVID-Module-NI/udsf-9v7b/about_data
Physician Experiences Related to COVID-19 from the National Ambulatory Medical Care Survey

The National Ambulatory Medical Care Survey (NAMCS), conducted by the National Center for Health Statistics (NCHS), collects data on visits to physician offices to describe patterns of ambulatory care delivery in the United States. As part of NAMCS, the Physician Induction Interview collects information about practice characteristics at physician offices. Partway through the 2020 NAMCS, NCHS added questions to the Physician Induction Interview to assess physician experiences related to COVID-19 in office-based settings.

The data include nationally representative estimates of experiences related to COVID-19 among office-based physicians in the United States, including: shortages of personal protective equipment (PPE) in the past 3 months; the ability to test for COVID-19 in the past 3 months; providers testing positive for COVID-19 in the past 3 months; turning away COVID-19 patients in the past 3 months; and telemedicine or telehealth technology use before and after March 2020.  Estimates were derived from interviews with physicians in periods 3 and 4 of 2020 NAMCS and periods 1 through 4 of 2021 NAMCS, which occurred between December 15, 2020 and May 6, 2022.  The data are considered preliminary, and the results may change with the final data release.